CA2865791C — Antifungal agents and uses thereof
Assigned to Cidara Therapeutics Inc · Expires 2019-10-08 · 7y expired
What this patent protects
The invention features echinocandin class compounds that can be useful for the treatment of fungal infections. The echinocandin class compounds have been modified such that they can exhibit (i) activity against one or more fungal species or genera; (ii) increased aqueous solubili…
USPTO Abstract
The invention features echinocandin class compounds that can be useful for the treatment of fungal infections. The echinocandin class compounds have been modified such that they can exhibit (i) activity against one or more fungal species or genera; (ii) increased aqueous solubility and/or amphiphilicity; (iii) have an increased therapeutic index; (iv) suitability for topical administration; (v) suitability for intravenous administration; (vi) have an increased volume of distribution; and/or (vii) have an increased elimination half-life.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.